Completed
Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder
NCT03169816
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Substance Treatment and Research Service (STARS), Columbia University New York, United States